Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.420
-0.030 (-2.07%)
At close: Jul 24, 2026, 4:00 PM EDT
1.400
-0.020 (-1.41%)
After-hours: Jul 24, 2026, 7:36 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,874,582
Market Cap
6.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| Purple Biotech | 10 |
| Alzamend Neuro | 6 |
| Jupiter Neurosciences | 5 |
| Cadrenal Therapeutics | 5 |
| Kairos Pharma | 4 |
| Addex Therapeutics | 3 |
ACXP News
- 11 days ago - Acurx’s ibezapolstat shows microbe preservation efficacy - TheFly
- 11 days ago - Acurx Pharmaceuticals Announces Scientific Poster Presentation of Ibezapolstat's Microbiome Preservation Data in Multiply-recurrent C. difficile Infection - PRNewsWire
- 17 days ago - Acurx Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 14, 2026 Conference Call and Provide Business Update - PRNewsWire
- 5 weeks ago - Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Leiden Early Drug Discovery & Development (LED3) Scientific Conference - PRNewsWire
- 2 months ago - Acurx Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Acurx Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 2 months ago - Acurx Pharmaceuticals Earnings release: Q1 2026 - Filings
- 2 months ago - Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update - PRNewsWire